Akero Therapeutics, Inc.·4

Jun 5, 4:05 PM ET

Xu Yuan 4

4 · Akero Therapeutics, Inc. · Filed Jun 5, 2025

Insider Transaction Report

Form 4
Period: 2025-06-03
Xu Yuan
Director
Transactions
  • Award

    Common Stock

    2025-06-03+9,3989,398 total
Footnotes (1)
  • [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs shall vest in full on the earlier of (i) June 3, 2026, and (ii) the next annual meeting of the Company's stockholders, subject to the director's continued service on the Board.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4